SynCore Biotechnology Stock Forecast - Accumulation Distribution
| 4192 Stock | TWD 35.60 0.05 0.14% |
SynCore Stock Forecast is based on your current time horizon.
SynCore |
| Check SynCore Biotechnology Volatility | Backtest SynCore Biotechnology | Information Ratio |
SynCore Biotechnology Trading Date Momentum
| On December 10 2024 SynCore Biotechnology Co was traded for 35.60 at the closing time. The highest price during the trading period was 35.60 and the lowest recorded bid was listed for 35.05 . The volume for the day was 7 K. This history from December 10, 2024 did not result in any price rise and fall. The trading price change to the current price is 1.54% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare SynCore Biotechnology to competition |
Other Forecasting Options for SynCore Biotechnology
For every potential investor in SynCore, whether a beginner or expert, SynCore Biotechnology's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. SynCore Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in SynCore. Basic forecasting techniques help filter out the noise by identifying SynCore Biotechnology's price trends.SynCore Biotechnology Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with SynCore Biotechnology stock to make a market-neutral strategy. Peer analysis of SynCore Biotechnology could also be used in its relative valuation, which is a method of valuing SynCore Biotechnology by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
SynCore Biotechnology Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of SynCore Biotechnology's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of SynCore Biotechnology's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
SynCore Biotechnology Market Strength Events
Market strength indicators help investors to evaluate how SynCore Biotechnology stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading SynCore Biotechnology shares will generate the highest return on investment. By undertsting and applying SynCore Biotechnology stock market strength indicators, traders can identify SynCore Biotechnology Co entry and exit signals to maximize returns.
SynCore Biotechnology Risk Indicators
The analysis of SynCore Biotechnology's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in SynCore Biotechnology's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting syncore stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 0.9122 | |||
| Standard Deviation | 1.33 | |||
| Variance | 1.77 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Pair Trading with SynCore Biotechnology
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if SynCore Biotechnology position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SynCore Biotechnology will appreciate offsetting losses from the drop in the long position's value.Moving together with SynCore Stock
| 0.88 | 4743 | Oneness Biotech | PairCorr |
| 0.88 | 6547 | Medigen Vaccine Biologics | PairCorr |
| 0.83 | 4174 | OBI Pharma | PairCorr |
Moving against SynCore Stock
| 0.72 | 2609 | Yang Ming Marine | PairCorr |
| 0.66 | 1449 | Chia Her Industrial Split | PairCorr |
| 0.63 | 0050 | YuantaP shares Taiwan | PairCorr |
| 0.56 | 0057 | Fubon MSCI Taiwan | PairCorr |
| 0.5 | 4162 | PharmaEngine | PairCorr |
The ability to find closely correlated positions to SynCore Biotechnology could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace SynCore Biotechnology when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back SynCore Biotechnology - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling SynCore Biotechnology Co to buy it.
The correlation of SynCore Biotechnology is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as SynCore Biotechnology moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if SynCore Biotechnology moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for SynCore Biotechnology can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for SynCore Stock Analysis
When running SynCore Biotechnology's price analysis, check to measure SynCore Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SynCore Biotechnology is operating at the current time. Most of SynCore Biotechnology's value examination focuses on studying past and present price action to predict the probability of SynCore Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SynCore Biotechnology's price. Additionally, you may evaluate how the addition of SynCore Biotechnology to your portfolios can decrease your overall portfolio volatility.